Items where Author is "Salari, S."

Article

(2022) Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial. BMC Cancer. p. 10.

(2021) Transcription analysis of a histones modifiers panel coupled with critical tumor suppressor genes displayed frequent changes in patients with AML. mRNA levels of histones modifiers and TSGs in AML. CURRENT RESEARCH IN TRANSLATIONAL MEDICINE. ISSN 2452-3186 J9 - CURR RES TRANSL MED

(2020) Efficacy and Safety of Proposed Bevacizumab Biosimilar BE1040V in Patients With Metastatic Colorectal Cancer: A Phase III, Randomized, Double-blind, Noninferiority Clinical Trial. Clinical Therapeutics. pp. 848-859. ISSN 0149-2918

(2019) A Rare Presentation of Acute Myelogenous Leukemia: A Case Report of Vaginal and Uterine Myeloid Sarcoma from Iran. Middle East Journal of Cancer. pp. 263-269. ISSN 2008-6709

(2018) Modeling Environmental UV and Gamma Radiations for Health Protection. Health Scope. ISSN 2251-8959

(2018) Transcription factors LEF1, PU.1 and IRF8 have decreased expression levels in majority of de novo acute myeloid leukemia patients. World Family Medicine. pp. 207-217. ISSN 1839-0188

(2018) The evaluation of p21 and p27 expression in HLA-DR negative AML patients. World Family Medicine. pp. 252-257. ISSN 1839-0188

(2018) The evaluation of the TGF- beta 1 and T beta RII gene expression in patients with acute lymphoblastic leukemia. World Family Medicine. pp. 198-206. ISSN 1839-0188